Evidence map›Paper›PMID 27209443›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2016

Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.

James P Lash, Ana C Ricardo, Jason Roy, Rajat Deo, Michael Fischer, John Flack, Jiang He, Martin Keane, Claudia Lora, Akinlolu Ojo and 7 more

Abstract readComparative Study
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Cardiovascular Disease in CKD: Ethnic and Regional Differences in Risk and Phenotype.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Frailty and Cardiovascular Outcomes in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  11. Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  12. Prospective associations of health literacy with clinical outcomes in adults with CKD: findings from the CRIC study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  13. New eGFR equations: Implications for cardiologists and racial inequities.American heart journal plus : cardiology research and practice · 2023
    Article
  14. Review
  15. Self-reported Physical Activity and Cardiovascular Events in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Article
  16. Race, Interleukin-6,Journal of the American Heart Association · 2022
    Article
  17. Article
  18. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

James P LashDepartment of Medicine, University of Illinois at Chicago, Chicago, IL. Electronic address: jplash@uic.edu.
Ana C RicardoDepartment of Medicine, University of Illinois at Chicago, Chicago, IL.
Jason RoyCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA.
Rajat DeoCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA.
Michael FischerDepartment of Medicine, University of Illinois at Chicago, Chicago, IL; Center of Complex Chronic Healthcare, Jesse Brown VA Medical Center, Chicago, IL.
John FlackDepartment of Internal Medicine, Southern Illinois University School of Medicine, Springfield, IL.
Jiang HeDepartment of Epidemiology, Tulane University, New Orleans, LA.
Martin KeaneDepartment of Medicine, Temple University, Philadelphia, PA.
Claudia LoraDepartment of Medicine, University of Illinois at Chicago, Chicago, IL.
Akinlolu OjoDepartment of Medicine, University of Michigan, Ann Arbor, MI.
Mahboob RahmanDepartment of Medicine, Case Western University, University Hospitals Case Medical Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH.
Susan SteigerwaltRenaissance Renal Research Institute, St. John's Hospital, Detroit, MI.
Kaixiang TaoCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA.
Myles WolfDepartment of Medicine, Northwestern University, Chicago, IL.
Jackson T WrightDepartment of Medicine, University of Michigan, Ann Arbor, MI.
Alan S GoKaiser Permanente Northern California Division of Research, Oakland, CA; Department of Epidemiology, University of California, San Francisco, San Francisco, CA; Department of Biostatistics, University of California, San Francisco, San Francisco, CA; Department of Medicine, University of California, San Francisco, San Francisco, CA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA.
CRIC Study Investigators
University of Illinois Chicago · USUniversity of Michigan · USUniversity of Pennsylvania · USKaiser Permanente · USTulane University · USUniversity Hospitals Cleveland Medical Center · USNorthwestern University · USRenal Research Institute · USSouthern Illinois University School of Medicine · USTemple University · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Scientific and Data Coordinating Center(SDCC) for the P*U01DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2001 to 2017
$50.1M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Zonulin Antibodies in Intestinal Permeabilitiy in IDDMM01RR016500 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI ONUKWUGHA, EBERECHUKWU · 2002 to 2009
$20.2M
Study of the Care and Outcomes of REnal InsufficiencyU01DK060902 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2001 to 2025
$19.5M
Limited Competition for the Continuation of the Chronic Renal Insufficiency CohorU01DK061021 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI RAHMAN, MAHBOOB · 2001 to 2025
$17.3M
Prospective Renal Insufficiency Cohort Evaluation:PRICEU01DK060984 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI COHEN, DEBBIE L · 2001 to 2025
$17.0M
Prospective Cohort Study of Chronic Renal InsufficiencyU01DK061028 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, PANDURANGA S · 2001 to 2025
$16.9M
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Hopkins Clinical CenterU01DK061022 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI APPEL, LAWRENCE JOHN · 2001 to 2025
$15.7M
Proposal for a Chicago-CRIC Clinical CenterU01DK060980 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LASH, JAMES P. · 2001 to 2025
$15.4M
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1 TR000439NCRR NIH HHS M01 RR016500NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR029879NIDDK NIH HHS K23 DK091313NIDDK NIH HHS K23 DK094829NIDDK NIH HHS K24 DK092290NIDDK NIH HHS K24 DK093723NIDDK NIH HHS R01 DK072231NIDDK NIH HHS R01 DK076116NIDDK NIH HHS R01 DK081374NIDDK NIH HHS R01 DK094796NIDDK NIH HHS R01 DK139225NIDDK NIH HHS R21 DK100754NIDDK NIH HHS R56 DK072231NIDDK NIH HHS U01 DK060902NIDDK NIH HHS U01 DK060963NIDDK NIH HHS U01 DK060980NIDDK NIH HHS U01 DK060984NIDDK NIH HHS U01 DK060990NIDDK NIH HHS U01 DK061021NIDDK NIH HHS U01 DK061022NIDDK NIH HHS U01 DK061028NIDDK NIH HHS U01 DK099930NIGMS NIH HHS P30 GM103337NIMHD NIH HHS P60 MD002265
6 · The paper itself

Abstract

backgroundNon-Hispanic blacks and Hispanics with end-stage renal disease have a lower risk for death than non-Hispanic whites, but data for racial/ethnic variation in cardiovascular outcomes for non-dialysis-dependent chronic kidney disease are limited. STUDY

designProspective cohort. SETTING &

participants3,785 adults with entry estimated glomerular filtration rates of 20 to 70mL/min/1.73m(2) enrolled in the CRIC (Chronic Renal Insufficiency Cohort) Study. PREDICTORS: Race/ethnicity (non-Hispanic white, non-Hispanic black, and Hispanic). OUTCOMES: Cardiovascular outcomes (atherosclerotic events [myocardial infarction, stroke, or peripheral arterial disease] and heart failure) and a composite of each cardiovascular outcome or all-cause death. MEASUREMENTS: Multivariable Cox proportional hazards.

resultsDuring a median follow-up of 6.6 years, we observed 506 atherosclerotic events, 551 heart failure events, and 692 deaths. In regression analyses, there were no significant differences in atherosclerotic events among the 3 racial/ethnic groups. In analyses stratified by clinical site, non-Hispanic blacks had a higher risk for heart failure events (HR, 1.59; 95% CI, 1.29-1.95), which became nonsignificant after adjustment for demographic factors and baseline kidney function. In contrast, Hispanics had similar risk for heart failure events as non-Hispanic whites. In analyses stratified by clinical site, compared with non-Hispanic whites, non-Hispanic blacks were at similar risk for atherosclerotic events or death. However, after further adjustment for cardiovascular risk factors, medications, and mineral metabolism markers, non-Hispanic blacks had 17% lower risk for the outcome (HR, 0.83; 95% CI, 0.69-0.99) than non-Hispanic whites, whereas there was no significant association with Hispanic ethnicity. LIMITATIONS: Hispanics were largely recruited from a single center, and the study was underpowered to evaluate the association between Hispanic ethnicity and mortality.

conclusionsThere were no significant racial/ethnic differences in adjusted risk for atherosclerotic or heart failure outcomes. Future research is needed to better explain the reduced risk for atherosclerotic events or death in non-Hispanic blacks compared with non-Hispanic whites.

Indexed as

EthnicityRacial GroupsAtherosclerosisCardiovascular DiseasesFemaleHeart FailureHumansMaleMiddle AgedProspective StudiesRenal Insufficiency, Chronicatherosclerotic cardiovascular eventsCRIC (Chronic Renal Insufficiency Cohort)dialysisend-stage renal disease (ESRD)ethnicityheart failureHispanicHispanic CRICRaceracial disparitiesracial/ethnic variationsurvival paradox

Identifiers

PMID27209443
PMCPMC5295809
OpenAlexW2395501101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.